| Dr Kevin Brian St John, MD | |
|
2003 Springwood Rd, York, PA 17403-4836 | |
| (717) 851-2521 | |
| (717) 260-3330 |
| Full Name | Dr Kevin Brian St John |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 45 Years |
| Location | 2003 Springwood Rd, York, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801824891 | NPI | - | NPPES |
| 233290 | Other | PA | MAMSI-WMG |
| 4389930 | Other | PA | AETNA |
| 80737 | Other | PA | UNISON-WMG |
| 097074 | Other | PA | HIGHMARK BLUE SHIELD |
| 01107503 | Other | PA | CAPITAL BLUE CROSS-WMG |
| 1142448 | Other | PA | AMERIHEALTH MERCY-WMG |
| 7273 | Other | PA | GEISINGER |
| P002885 | Other | PA | GATEWAY-WMG |
| 30047 | Other | PA | JOHNS HOPKINS |
| 542988 | Other | MD | CAREFIRST MD BCBS |
| 001079856 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD036023E (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced three grants worth a total of US$6.8 million to speed the development of innovative drugs for some of the world's most neglected diseases—schistosomiasis, Chagas disease and parasitic roundworms.
A handful of FDA-approved drugs exist for treating individuals with alcohol use disorder but they have been largely ineffective at reducing the high rates of relapse. As such, there remains a critical need to identify and develop alternative pharmacological treatment options.
Isogenica Ltd today announced that it has entered into an agreement with Australian based biopharmaceutical company Phylogica to use Isogenica's CIS display technology to optimize the performance of three of Phylogica's lead compounds targeting CD40 ligand (CD40L). CD40L is a key protein involved in many inflammatory diseases, such as Rheumatoid Arthritis and Inflammatory Bowel Disease.
As electronic health record systems become more interconnected, errors may propagate much farther than under old paper-based systems, a recent study suggested. According to a review by the Pennsylvania Patient Safety Authority, mistakes and near misses involving electronic health records were analogous to those made with paper-based records with one caveat: those made with EHRs tend to be amplified and can affect a larger group of people.
› Verified 5 days ago
| Entity Name | York Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326060492 PECOS PAC ID: 2961307467 Enrollment ID: O20031205000629 |
News Archive
The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced three grants worth a total of US$6.8 million to speed the development of innovative drugs for some of the world's most neglected diseases—schistosomiasis, Chagas disease and parasitic roundworms.
A handful of FDA-approved drugs exist for treating individuals with alcohol use disorder but they have been largely ineffective at reducing the high rates of relapse. As such, there remains a critical need to identify and develop alternative pharmacological treatment options.
Isogenica Ltd today announced that it has entered into an agreement with Australian based biopharmaceutical company Phylogica to use Isogenica's CIS display technology to optimize the performance of three of Phylogica's lead compounds targeting CD40 ligand (CD40L). CD40L is a key protein involved in many inflammatory diseases, such as Rheumatoid Arthritis and Inflammatory Bowel Disease.
As electronic health record systems become more interconnected, errors may propagate much farther than under old paper-based systems, a recent study suggested. According to a review by the Pennsylvania Patient Safety Authority, mistakes and near misses involving electronic health records were analogous to those made with paper-based records with one caveat: those made with EHRs tend to be amplified and can affect a larger group of people.
› Verified 5 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced three grants worth a total of US$6.8 million to speed the development of innovative drugs for some of the world's most neglected diseases—schistosomiasis, Chagas disease and parasitic roundworms.
A handful of FDA-approved drugs exist for treating individuals with alcohol use disorder but they have been largely ineffective at reducing the high rates of relapse. As such, there remains a critical need to identify and develop alternative pharmacological treatment options.
Isogenica Ltd today announced that it has entered into an agreement with Australian based biopharmaceutical company Phylogica to use Isogenica's CIS display technology to optimize the performance of three of Phylogica's lead compounds targeting CD40 ligand (CD40L). CD40L is a key protein involved in many inflammatory diseases, such as Rheumatoid Arthritis and Inflammatory Bowel Disease.
As electronic health record systems become more interconnected, errors may propagate much farther than under old paper-based systems, a recent study suggested. According to a review by the Pennsylvania Patient Safety Authority, mistakes and near misses involving electronic health records were analogous to those made with paper-based records with one caveat: those made with EHRs tend to be amplified and can affect a larger group of people.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Brian St John, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 851-2521 | Dr Kevin Brian St John, MD 2003 Springwood Rd, York, PA 17403-4836 Ph: (717) 851-2521 |
News Archive
The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced three grants worth a total of US$6.8 million to speed the development of innovative drugs for some of the world's most neglected diseases—schistosomiasis, Chagas disease and parasitic roundworms.
A handful of FDA-approved drugs exist for treating individuals with alcohol use disorder but they have been largely ineffective at reducing the high rates of relapse. As such, there remains a critical need to identify and develop alternative pharmacological treatment options.
Isogenica Ltd today announced that it has entered into an agreement with Australian based biopharmaceutical company Phylogica to use Isogenica's CIS display technology to optimize the performance of three of Phylogica's lead compounds targeting CD40 ligand (CD40L). CD40L is a key protein involved in many inflammatory diseases, such as Rheumatoid Arthritis and Inflammatory Bowel Disease.
As electronic health record systems become more interconnected, errors may propagate much farther than under old paper-based systems, a recent study suggested. According to a review by the Pennsylvania Patient Safety Authority, mistakes and near misses involving electronic health records were analogous to those made with paper-based records with one caveat: those made with EHRs tend to be amplified and can affect a larger group of people.
› Verified 5 days ago
Dr. Sahil Jain, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1001 S George St, York Hospital, York, PA 17403 Phone: 717-851-2521 | |
Dr. Robert John Pizziketti, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 810 Bonneview Rd, York, PA 17402 Phone: 717-852-7766 Fax: 717-852-7862 | |
Dr. Michael A Wilson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4222 Lincoln Hwy, York, PA 17406 Phone: 717-812-2050 Fax: 717-812-2052 | |
Barry A Rott, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 S George St, York Hospital, York, PA 17403 Phone: 717-851-2521 Fax: 717-851-3535 | |
Asceline So Go, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 S George St, Suite 200, York, PA 17401 Phone: 717-845-8617 Fax: 717-854-6645 | |
Dr. Cathy P. Carpenter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Wyntre Brooke Dr, York, PA 17403 Phone: 717-741-9462 Fax: 717-741-4399 | |
Patrick Michael Sterling, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2730 |